Qiang Xu
Wannan Medical College(CN)Qingdao University(CN)Xiamen University(CN)Heidelberg University(DE)Fudan University(CN)Southwest Medical University(CN)Chengdu University of Technology(CN)Zhejiang Cancer Hospital(CN)Affiliated Hospital of Qingdao University(CN)Jinhua Academy of Agricultural Sciences(CN)Zhongshan Hospital(CN)University Medical Centre Mannheim(DE)Jinhua Central Hospital(CN)Children’s Hospital of Fudan University Xiamen Branch(CN)Hangzhou Cancer Hospital(CN)Sichuan University of Science and Engineering(CN)
Publications by Year
Research Areas
Ocular Infections and Treatments, Cancer Genomics and Diagnostics, Liver Disease Diagnosis and Treatment, Acute Myeloid Leukemia Research, Hepatitis C virus research
Most-Cited Works
- → Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia(2017)1,447 cited
- → FDA Approval: Ado-Trastuzumab Emtansine for the Treatment of Patients with HER2-Positive Metastatic Breast Cancer(2014)339 cited
- → Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib(2018)323 cited
- → Enasidenib, an inhibitor of mutant IDH2 proteins, induces durable remissions in older patients with newly diagnosed acute myeloid leukemia(2019)248 cited
- → Insulin Resistance and Risk of Ischemic Stroke Among Nondiabetic Individuals From the Northern Manhattan Study(2010)170 cited
- → Improving Global Vascular Risk Prediction With Behavioral and Anthropometric Factors(2009)105 cited